Synopsis of recent research by authors named "Chong Cheng"
- Chong Cheng's recent research focuses on the development of innovative nanobiocatalysts and biocatalytic strategies for addressing complex biomedical challenges, including diabetic wound healing, cancer therapies, and combating drug-resistant bacteria.
- A notable finding includes the design of an oxygen-bonded amorphous transition metal dichalcogenide biocatalyst that offers pH-responsive reactive oxygen species (ROS) for effective antibacterial and anti-inflammatory treatments in diabetic wound healing environments.
- Additionally, Cheng's work highlights the engineering of bacteriophage-inspired nanobiocatalysts and NADPH oxidase-mimicking reactive oxygen biocatalysts, showing potential for enhancing immunotherapy responses in cancer and offering nonantibiotic solutions against resistant bacterial strains.